Edwin Zhang
Stock Analyst at HC Wainwright & Co.
(0.01)
# 4,365
Out of 4,831 analysts
5
Total ratings
20%
Success rate
-48.13%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Edwin Zhang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RARE Ultragenyx Pharmaceutical | Initiates: Buy | $106 | $35.40 | +199.44% | 1 | Sep 30, 2021 | |
| LOGC ContextLogic | Initiates: Buy | $15 | $7.69 | +95.19% | 1 | Jun 7, 2021 | |
| FGEN FibroGen | Downgrades: Neutral | n/a | $0.30 | - | 2 | Apr 7, 2021 | |
| ALDX Aldeyra Therapeutics | Initiates: Buy | $26 | $2.08 | +1,150.00% | 1 | Feb 8, 2021 |
Ultragenyx Pharmaceutical
Sep 30, 2021
Initiates: Buy
Price Target: $106
Current: $35.40
Upside: +199.44%
ContextLogic
Jun 7, 2021
Initiates: Buy
Price Target: $15
Current: $7.69
Upside: +95.19%
FibroGen
Apr 7, 2021
Downgrades: Neutral
Price Target: n/a
Current: $0.30
Upside: -
Aldeyra Therapeutics
Feb 8, 2021
Initiates: Buy
Price Target: $26
Current: $2.08
Upside: +1,150.00%